524661 WELCURE

Welcure Drugs & Pharmaceuticals Share Price Welcure Drugs & Pharmaceuticals

₹4.85
+0.23 (4.98%)
23 April, 2024 20:57 BSE: 524661 NSE: WELCUREISIN: INE331C01017

Start SIP in Welcure Drugs & Pharmaceuticals

Start SIP

Welcure Drugs & Pharmaceuticals Performance

Day Range

  • Low 0
  • High 0
₹ 4

52 Week Range

  • Low 0
  • High 0
₹ 4
  • Open Price0
  • Previous Close0
  • Volume

Welcure Drugs & Pharmaceuticals Share Price

  • Over 1 Month +21.55%
  • Over 3 Month +10.23%
  • Over 6 Month +25.97%
  • Over 1 Year +24.36%

Welcure Drugs & Pharmaceuticals Key Statistics

Welcure Drugs & Pharmaceuticals Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 0000
Operating Expenses Qtr Cr 0000
Operating Profit Qtr Cr 0000
Depreciation Qtr Cr 0000
Interest Qtr Cr 0000
Tax Qtr Cr 0000
Net Profit Qtr Cr 0000
IndicatorMar 2023
Total Revenue Annual Cr 0
Operating Expenses Annual Cr 0
Operating Profit Annual in Cr 0
Depreciation Cr 0
Interest Annual Cr 0
Tax Annual Cr 0
Net Profit Annual Cr 0
IndicatorMar 2023
Cash from Operating Activity Annual Cr 0
Cash from Investing Activity Annual Cr 1
Cash from Financing Annual Activity Cr -1
Net Cash Flow Annual Cr 0
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 2
Fixed Assets Annual Cr 0
Total Non Current Assets Annual Cr 2
Total Current Assets Annual Cr 0
Total Assets Annual Cr 2
IndicatorMar 2023
Book Value Per Share Annual Rs 1
ROE Annual % 7
ROCE Annual % 7
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 0
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual -
EBDIT Annual Margin %

Welcure Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹4.85
+0.23 (4.98%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹4.53
  • 50 Day
  • ₹4.47
  • 100 Day
  • ₹4.40
  • 200 Day
  • ₹4.40
  • 20 Day
  • ₹4.43
  • 50 Day
  • ₹4.52
  • 100 Day
  • ₹4.41
  • 200 Day
  • ₹4.14

Welcure Drugs & Pharmaceuticals Resistance and Support

PIVOT
₹4.79
Resistance
First Resistance 4.92
Second Resistance 4.98
Third Resistance 5.12
RSI 58.56
MFI 69.87
MACD Single Line 0.07
MACD 0.10
Support
First Resistance 4.72
Second Resistance 4.58
Third Resistance 4.52

Welcure Drugs & Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 48,189 4,414,112 91.6
Week 29,035 2,464,491 84.88
1 Month 25,302 2,314,647 91.48
6 Month 32,748 2,966,984 90.6

Welcure Drugs & Pharmaceuticals Result Highlights

Welcure Drugs & Pharmaceuticals Synopsis

BSE-Medical-Biomed/Biotech

Welcure Drugs & is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 13.44 Cr. for the Year ended 31/03/2023. Welcure Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 06/08/1996 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L24232DL1996PLC227773 and registration number is 227773.
Market Cap 6
Sales
Shares in Float 1.35
No of funds
Yield
Book Value 4.29
U/D Vol ratio 0.9
LTDebt / Equity
Alpha -0.04
Beta 0.94

Welcure Drugs & Pharmaceuticals

Owner NameMar-24Dec-23Sep-23Jun-23
Promoters
Individual Investors 93.7%93.87%94.29%93.67%
Others 6.3%6.13%5.71%6.33%

Welcure Drugs & Pharmaceuticals Management

Name Designation
Mr. Vishal Mehra Managing Director
Mrs. Sitaben S Patel Ind. Non-Executive Director
Mr. Rajeev Mehra Ind. Non-Executive Director
Mr. Mayank Bhandari Ind. Non-Executive Director

Welcure Drugs & Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Welcure Drugs & Pharmaceuticals Corporate Action

Date Purpose Remarks
2024-03-28 Others Inter alia, (1) To Consider and Approve the Resignation of M/s BMGS &Associates Accountant of the Company.
2024-02-14 Quarterly Results
2023-11-14 Quarterly Results
2023-08-14 Quarterly Results
2023-07-11 Quarterly Results

Welcure Drugs & Pharmaceuticals MF Shareholding

Name Amount(cr)

Welcure Drugs & Pharmaceuticals FAQs

What is Share Price of Welcure Drugs & Pharmaceuticals ?

Welcure Drugs & Pharmaceuticals share price is ₹4 As on 23 April, 2024 | 20:43

What is the Market Cap of Welcure Drugs & Pharmaceuticals ?

The Market Cap of Welcure Drugs & Pharmaceuticals is ₹6.6 Cr As on 23 April, 2024 | 20:43

What is the P/E ratio of Welcure Drugs & Pharmaceuticals ?

The P/E ratio of Welcure Drugs & Pharmaceuticals is 568.6 As on 23 April, 2024 | 20:43

What is the PB ratio of Welcure Drugs & Pharmaceuticals ?

The PB ratio of Welcure Drugs & Pharmaceuticals is 4.3 As on 23 April, 2024 | 20:43

Q2FY23